Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Attention deficit hyperactivity disorder in children

https://doi.org/10.14412/2074-2711-2014-1-4-8

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common neuropsychological disorder occurring in 5-8% of school-aged children. In case of late diagnosis and lack of correction, this condition may lead to intra-family problems and formation of antisocial behavior, which largely determines the relevance of the research into ADHD. The main clinical manifestations of ADHD include attention deficit, hyperactivity and impulsivity, as well as symptoms of staticolocomotory deficiency. The pathogenesis, diagnosis, and treatment of ADHD are discussed. 

About the Authors

O.E. Zinov'eva
Department of Nervous Diseases and Neurosurgery, I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
Russian Federation


E.G. Rogovina
Department of Nervous Diseases and Neurosurgery, I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, Russia


E.A. Tyrinova
Department of Nervous Diseases and Neurosurgery, I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
Russian Federation


References

1. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–8. DOI: <a="http://dx.doi.org/10.1176/appi.ajp.164.6.942">http://dx.doi.org/10.1176/appi.ajp.164.6.942</a>

2. Брязгунов ИП, Касатикова ЕВ. Дефицит внимания с гиперактивностью у детей. Москва: Медпрактика; 2002. 128 с. [Bryazgunov IP, Kasatikova EV. Defitsit vnimaniya s giperaktivnost'yu u detei [Deficiency of attention with a hyperactivity at children]. Moscow: Medpraktika; 2002. 128 p. (In Russ.)]

3. Заваденко НН. Гиперактивность и дефицит внимания в детском возрасте. Москва: ACADEMIA; 2005. 256 с. [Zavadenko NN. Giperaktivnost' i defitsit vnimaniya v detskom vozraste [Hyperactivity and deficiency of attention at children's age]. Moscow: ACADEMIA; 2005. 256 p. (In Russ.)]

4. Biederman J, Kwon A, Aleardi M, et al. Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects. Am J Psychiatry. 2005;162(6):1083–9. DOI: http://dx.doi.org/10.1176/appi.ajp.162.6.1083.

5. Diagnostic and Statistical Manual of Mental Disorders. 5th еd.: DSM-5. American Psychiatric Association. 2013.

6. Александров АА, Карпина НВ, Станкевич ЛН. Негативность рассогласования в вызванных потенциалах мозга у подростков в норме и при дефиците внимания при предъявлении акустических стимулов короткой длительности. Российский физиологический журнал им. И.М. Сеченова. 2003;33(7):671–5. [Aleksandrov AA, Karpina NV, Stankevich LN. Mismatch negativity in evoked brain potentials in adolescents in normal conditions and attention deficit in response to presentation of short-duration acoustic stimuli. Rossiiskii fiziologicheskii zhurnal im. I.M. Sechenova = Neuroscience and behavioral physiology. 2003;33(7):671–5. (In Russ.)]

7. Becker SP, Langberg JM, Vaughn AJ, Epstein JN. Clinical utility of the Vanderbilt ADHD diagnostic parent rating scale comorbidity screening scales. J Dev Behav Pediatr. 2012;33(3):221–8. DOI: 10.1097/DBP.0b013e318245615b.

8. Горбачевская НЛ, Заваденко НН, Сорокин АБ, Григорьева НВ. Нейрофизиологическое исследование синдрома дефицита внимания с гиперактивностью. Сибирский вестник психиатрии и наркологии. 2003;(1):47–51. [Gorbachevskaya NL, Zavadenko NN, Sorokin AB, Grigor'eva NV. Neurophysiological research of a syndrome of deficiency of attention with a hyperactivity. Sibirskii vestnik psikhiatrii i narkologii. 2003;(1):47–51. (In Russ.)]

9. Biederman J, Faraone S. Attention deficit hyperactivity disorder. Lancet. 2005;366(9481):237–48. DOI: http://dx.doi.org/10.1016/S0140-6736(05)66915-2.

10. Mick E, Faraone SV. Genetics of Attention Deficit Hyperactivity Disorder. Child Adolesc Psychiatr Clin N Am. 2008;17(2):261–84, vii-viii. DOI: 10.1016/j.chc.2007.11.011.

11. Haavik J, Blau N, Thö ny B. Mutations in human monoamine-related neurotransmitter pathway genes. Hum Mutat. 2008;29(7):891–902. DOI: 10.1002/humu.20700.

12. Schulz KP, Himelstein J, Halperin JM, Newcorn JH. Neurobiological models of attentiondeficit/hyperactivity disorder: a brief review of the empirical evidence. CNS spectrums. 2000;5(6):34–44.

13. Arnsten AFT, Pliszka SR. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit hyperactivity disorder and related disorders. Pharmacol Biochem Behav. 2011;99(2):211–6. DOI: 10.1016/j.pbb.2011.01.020. Epub 2011 Feb 2.

14. McNally MA, Crocetti D, Mahone EM, et al. Corpus callosum segment circumference is associated with response control in children with attention-deficit hyperactivity disorder (ADHD). J Child Neurology. 2010;25(4):453–62. DOI: 10.1177/0883073809350221. Epub 2010 Feb 5.

15. Nakao T, Radua J, Rubia K, Mataix-Cols D. Gray matter volume abnormalities in ADHD: voxelbased meta-analysis exploring the effects of age and stimulant medication. Am J Psychiatry. 2011;168(11):1154–63. DOI: 10.1176/appi.ajp.2011.11020281. Epub 2011 Aug 24.

16. Valera EM, Faraone SV, Murray KE, Seidman LJ. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61(12):1361–9. DOI: http://dx.doi.org/10.1016/j.biopsych.2006.06.011. Epub 2006 Sep 1.

17. Пальчик АБ. Лекции по неврологии развития. Москва: МЕДпреcсинформ; 2012. 376 с. [Pal'chik AB. Lektsii po nevrologii razvitiya [Lectures on development neurology]. Moscow: MEDprecsinform; 2012. 376 p. (In Russ.)]

18. Reddy DS. Neurosteroids: Endogenous role in the human brian and therapeutic potentials. Prog. Brain Res. 2010;186:113–137.

19. Shaw P, Eckstrand K, Sharp W, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA. 2007;104(49):19649–54. DOI: http://dx.doi.org/10.1073/pnas.0707741104. Epub 2007 Nov 16.

20. Fair DA, Posner J, Nagel BJ, et al. Atypical default network connectivity in youth with attention-deficit hyperactivity disorder. Biological psychiatry. 2010;68(12):1084–91. DOI: 10.1016/j.biopsych.2010.07.003. Epub 2010 Aug 21.

21. Makris N, Biederman J, Monuteaux MC,Seidman LJ. Towards Conceptualizing a Neural Systems-Based Anatomy of Attention-Deficit/Hyperactivity Disorder. Dev Neurosci. 2009;31(1–2):36–49. DOI: 10.1159/000207492. Epub 2009 Apr 17.

22. Kaplan RF, Stevens MC. A review of adult ADHD: a neuropsychological and neuroimaging perspective. CNS Spectrums. 2002;7(5):355–62.

23. Krause J. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev Neurother. 2008;8(4):611–25. DOI: 10.1586/14737175.8.4.611.

24. Zametkin A, Liebenauer L, Fitzgerald G, et al. Brain metabolism in teenagers with attention deficit hyperactivity disorder. Arch Gen Psychiatry. 1993;50:333–40. DOI: http://dx.doi.org/10.1001/archpsyc.1993.01820170011002.

25. Arns M, Conners CK, Kraemer HC. A decade of EEG Theta/Beta ratio research in ADHD – a meta-analysis. J Atten Disord. 2013;17(5):374–83. DOI: 10.1177/1087054712460087. Epub 2012 Oct 19.

26. Anjana Y, Khaliq F, Vaney N. Event-related potentials study in attention deficit hyperactivity disorder. Funct Neurol. 2010;25(2):87–92.

27. Oades RD, Dittman-Balcar A, Schepker R, et al. Auditory event-related potentials (ERPs) and mismatch negativity (MMN) in healthy children and those with attention-deficit or tourettetic symptoms. Biol Psychol. 1996;43(2):163–85. DOI: http://dx.doi.org/10.1016/0301-0511(96)05189-7.

28. Meisel V, Servera M, Garcia-Banda G, et al. Neurofeedback and standard pharmacological intervention in ADHD: a randomized controlled trial with six-month follow-up. Biol Psychol. 2013;94(1):12–21. DOI: http://dx.doi.org/10.1016/j.biopsycho.2013.04.015.

29. Wilens T, Spencer T, Biederman J. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(5):456–63. DOI: http://dx.doi.org/10.1016/j.biopsych.2004.11.043.

30. Lee SS, Humphreys KL, Flory K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev. 2011;31(3):328–41. DOI: http://dx.doi.org/10.1016/j.cpr.2011.01.006.

31. Hammerness P, McCarthy K, Mancuso E, et al. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review. Neuropsychiatr Dis Treat. 2009;5:215–26. Epub 2009 Apr 8.

32. Sangal RB, Sangal JM. Attention-deficit/hyperactivity disorder: using P300 topography to choose optimal treatment. Expert Rev Neurother. 2006;6(10):1429–37. DOI: http://dx.doi.org/10.1586/14737175.6.10.1429.


Review

Views: 51343


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)